Expert Ratings for Exact Sciences
Portfolio Pulse from Benzinga Insights
Exact Sciences (NASDAQ:EXAS) has received mostly bullish ratings from analysts in the last quarter, with 11 out of 14 ratings being bullish. The average 12-month price target for the company has increased by 16.14% from the previous average, now standing at $95.0.
July 21, 2023 | 8:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Exact Sciences has received mostly bullish ratings from analysts, indicating a positive outlook for the company. The increased average price target suggests potential upside for the stock.
The majority of analyst ratings for Exact Sciences are bullish, indicating a positive sentiment towards the company. The increase in the average price target suggests that analysts believe the stock has potential for growth, which could positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100